Abdulkader Jamal Eddin: ABO Blood Group, COVID-19 and Early Respiratory Outcomes in Acute PE
Abdulkader Jamal Eddin, Gastroenterology Resident at “Pius Brînzeu” County Emergency Clinical Hospital, Timişoara, shared on LinkedIn about a recent article he and his colleagues co-authored, published in Journal of Cardiovascular Development and Disease, adding:
”I am pleased to share our latest publication:
‘ABO Blood Group Modifies the Association Between COVID-19 and Early Respiratory Outcomes in Acute Pulmonary Embolism’
Published in the Journal of Cardiovascular Development and Disease.
This study explores the relationship between ABO blood group, COVID-19, and early outcomes in patients with acute pulmonary embolism.
Many thanks to my co-authors and mentors for their collaboration.”
Title: Association Between ABO Blood Group, COVID-19 Status, and Early Respiratory Outcomes in Acute Pulmonary Embolism: An Interaction Analysis
Authors: Abdulkader Jamal Eddin, Stefan-Iulian Stanciugelu, Arnaldo Dario Damian, Diana Nitusca, Oana Elena Tunea, Ioana Monica Mozos
Stay updated on all scientific advances with Hemostasis Today.
-
Nov 9, 2026, 13:48PF4-ELISA–Negative HIT: Are We Missing a New Class of Anti-PF4 Immunothrombotic Disease?
-
Nov 9, 2026, 13:07Nandini Sadasivam: Gene Therapy for Sickle Cell Disease and Thalassaemia
-
Nov 9, 2026, 13:04Raising Awareness of Bleeding Disorders in Women and Girls – EHC
-
Nov 9, 2026, 12:59Rahul Bohra: Exploring the Complex Mechanisms of Sickle Cell Disease
-
Nov 9, 2026, 12:53Three Years of Movement and Thrombosis Awareness in the Czech Republic – World Thrombosis day
-
Nov 9, 2026, 12:51Octavio Marques Pontes-Neto: Intensive Blood-Pressure Control Reduces Cardiovascular Events After Ischemic Stroke
-
Nov 9, 2026, 12:49Irma Bagdoniene: What Really Makes Us Live Longer
-
Nov 9, 2026, 12:47Imo Akpan: Announcing the 2027 Women’s Hematology Summit
-
Nov 9, 2026, 12:45Shadi Yaghi: Rethinking Antithrombotic Therapy After Stroke